Talis Biomedical to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
April 28 2021 - 8:00AM
Talis Biomedical Corporation (“TLIS”), a company dedicated to
developing innovative molecular diagnostic tests for infectious
diseases at the point-of-care, today announced that the company
will be participating in the BofA Securities 2021 Virtual
Healthcare Conference.
Talis Biomedical’s management is scheduled to participate in the
conference on Wednesday, May 12, 2021, at 8:00 a.m. Pacific Time /
11:00 a.m. Eastern Time. Interested parties can access the live and
archived webcast via the News & Events page of the investor
section of the company’s website at www.talis.bio.
About Talis BiomedicalTalis is dedicated to
transforming diagnostic testing by developing and commercializing
innovative products that are designed to enable accurate, low cost,
and rapid molecular testing for infectious diseases at the
point-of-care. The company is developing the Tails One, a compact,
sample-to-answer, cloud-enabled, molecular diagnostic platform. For
more information, visit www.talis.bio.
Investor ContactMedia & InvestorsEmily
Faucetteefaucette@talisbio.com415-595-9407
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Talis Biomedical (NASDAQ:TLIS)
Historical Stock Chart
From Apr 2023 to Apr 2024